GALT
Galectin Therapeutics Inc
NASDAQ: GALT · HEALTHCARE · BIOTECHNOLOGY
$3.93
+0.77% today
Updated 2026-09-28
Market cap
$393.31M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.43
Dividend yield
—
52W range
$2 – $7
Volume
0.3M
Galectin Therapeutics Inc (GALT) Insider transactions
Net insider activity
Net buying (34,529,881 shares)
Buy transactions
37
Sell transactions
63
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-31 | UIHLEIN, RICHARD E | Director, 10% Owner | Buy | 31,825,235 | $3.00 | $95.48M |
| 2026-07-31 | UIHLEIN, RICHARD E | Director, 10% Owner | Buy | 2,550,932 | $4.05 | $10.33M |
| 2026-07-14 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 16,250 | — | — |
| 2026-07-14 | JAMIL, KHURRAM | Chief Medical Officer | Buy | 16,250 | $3.04 | $49400.00 |
| 2026-06-29 | SHLEVIN, HAROLD H. | Director | Sale | 22,268 | — | — |
| 2026-06-29 | SHLEVIN, HAROLD H. | Director | Sale | 22,268 | $5.04 | $112230.72 |
| 2026-06-29 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 47,467 | — | — |
| 2026-06-29 | JAMIL, KHURRAM | Chief Medical Officer | Buy | 47,467 | $2.50 | $118667.50 |
| 2026-06-26 | SHLEVIN, HAROLD H. | Director | Sale | 7,732 | — | — |
| 2026-06-26 | SHLEVIN, HAROLD H. | Director | Buy | 7,732 | $1.23 | $9510.36 |
| 2026-06-26 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 2,533 | — | — |
| 2026-06-26 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 2,037 | — | — |
| 2026-06-26 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 2,533 | $5.00 | $12665.00 |
| 2026-06-26 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 2,037 | $5.00 | $10185.00 |
| 2026-06-23 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 7,557 | — | — |
| 2026-06-23 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 7,557 | $3.14 | $23728.98 |
| 2026-05-26 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 568 | — | — |
| 2026-05-26 | JAMIL, KHURRAM | Chief Medical Officer | Buy | 568 | $1.23 | $698.64 |
| 2026-03-12 | BREM, HENRY | Director | Buy | 60,000 | — | — |
| 2026-02-06 | ELDRED, KARY | Director | Buy | 300 | $2.70 | $810.00 |
| 2026-01-16 | ZORDANI, RICHARD A. JR. | Director | Buy | 60,000 | — | — |
| 2026-01-16 | UIHLEIN, RICHARD E | Director, 10% Owner | Buy | 60,000 | — | — |
| 2026-01-16 | UIHLEIN, RICHARD E | Director, 10% Owner | Buy | 13,158 | $3.04 | $40000.32 |
| 2026-01-16 | SHLEVIN, HAROLD H. | Director | Buy | 60,000 | — | — |
| 2026-01-16 | SCHWARTZ, ELISSA J. | Director | Buy | 60,000 | — | — |
| 2026-01-16 | OMENN, GILBERT S | Director | Buy | 60,000 | — | — |
| 2026-01-16 | LEWIS, JOEL | Director, President and CEO | Buy | 91,000 | — | — |
| 2026-01-16 | LEWIS, JOEL | Director, President and CEO | Buy | 84,000 | — | — |
| 2026-01-16 | LEWIS, JOEL | Director, President and CEO | Buy | 120,000 | — | — |
| 2026-01-16 | JAMIL, KHURRAM | Chief Medical Officer | Buy | 65,000 | — | — |
| 2026-01-16 | JAMIL, KHURRAM | Chief Medical Officer | Buy | 100,000 | — | — |
| 2026-01-16 | FREEMAN, KEVIN D | Director | Buy | 60,000 | — | — |
| 2026-01-16 | ELDRED, KARY | Director | Buy | 60,000 | — | — |
| 2026-01-16 | CARSON, BENJAMIN SR | Director | Buy | 60,000 | — | — |
| 2026-01-16 | CALLICUTT, JACK W | Chief Financial Officer | Buy | 65,000 | — | — |
| 2026-01-16 | CALLICUTT, JACK W | Chief Financial Officer | Buy | 100,000 | — | — |
| 2026-01-16 | AMELIO, GILBERT F | Director | Buy | 60,000 | — | — |
| 2026-01-06 | LEWIS, JOEL | Director, President and CEO | Sale | 37,698 | $3.58 | $134853.29 |
| 2026-01-06 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 21,446 | $3.65 | $78204.98 |
| 2026-01-06 | CALLICUTT, JACK W | Chief Financial Officer | Sale | 20,354 | $3.67 | $74695.11 |
| 2026-01-05 | LEWIS, JOEL | Director, President and CEO | Sale | 56,332 | $3.88 | $218568.16 |
| 2026-01-05 | LEWIS, JOEL | Director, President and CEO | Sale | 27,731 | $3.91 | $108342.24 |
| 2026-01-05 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 25,499 | $3.90 | $99407.85 |
| 2026-01-05 | CALLICUTT, JACK W | Chief Financial Officer | Sale | 25,732 | $3.90 | $100298.19 |
| 2026-01-02 | LEWIS, JOEL | Director, President and CEO | Sale | 84,000 | — | — |
| 2026-01-02 | LEWIS, JOEL | Director, President and CEO | Buy | 84,000 | — | — |
| 2026-01-02 | LEWIS, JOEL | Director, President and CEO | Sale | 18,571 | $4.20 | $77938.77 |
| 2026-01-02 | JAMIL, KHURRAM | Chief Medical Officer | Buy | 60,000 | — | — |
| 2026-01-02 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 13,055 | $4.20 | $54789.22 |
| 2026-01-02 | CALLICUTT, JACK W | Chief Financial Officer | Buy | 60,000 | — | — |
| 2026-01-02 | CALLICUTT, JACK W | Chief Financial Officer | Sale | 13,914 | $4.20 | $58394.28 |
| 2026-01-01 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 60,000 | — | — |
| 2026-01-01 | CALLICUTT, JACK W | Chief Financial Officer | Sale | 60,000 | — | — |
| 2025-12-31 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 8,125 | — | — |
| 2025-12-31 | JAMIL, KHURRAM | Chief Medical Officer | Buy | 8,125 | $1.23 | $9993.75 |
| 2025-12-23 | FREEMAN, KEVIN D | Director | Buy | 5,500 | $3.55 | $19514.00 |
| 2025-12-23 | ELDRED, KARY | Director | Buy | 700 | $3.73 | $2611.00 |
| 2025-12-17 | SHLEVIN, HAROLD H. | Director | Sale | 20,000 | — | — |
| 2025-12-17 | SHLEVIN, HAROLD H. | Director | Buy | 20,000 | $1.98 | $39600.00 |
| 2025-12-17 | SHLEVIN, HAROLD H. | Director | Sale | 19,793 | $7.04 | $139303.13 |
| 2025-12-17 | SHLEVIN, HAROLD H. | Director | Sale | 4,706 | $7.04 | $33120.83 |
| 2025-12-17 | LEWIS, JOEL | Director, President and CEO | Sale | 7,829 | — | — |
| 2025-12-17 | LEWIS, JOEL | Director, President and CEO | Sale | 7,829 | $7.06 | $55241.42 |
| 2025-12-17 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 8,500 | — | — |
| 2025-12-17 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 6,463 | — | — |
| 2025-12-17 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 8,500 | $7.04 | $59840.00 |
| 2025-12-17 | JAMIL, KHURRAM | Chief Medical Officer | Buy | 6,463 | $2.20 | $14218.60 |
| 2025-12-17 | JAMIL, KHURRAM | Chief Medical Officer | Sale | 4,479 | $7.04 | $31532.16 |
| 2025-12-16 | 10X, FUND, L.P. | 10% Owner | Sale | 30,681 | $6.66 | $204335.46 |
| 2025-12-15 | SHLEVIN, HAROLD H. | Director | Sale | 8,417 | — | — |
| 2025-12-15 | SHLEVIN, HAROLD H. | Director | Buy | 8,417 | $4.16 | $35014.72 |
| 2025-12-15 | SHLEVIN, HAROLD H. | Director | Sale | 8,417 | $6.30 | $53027.10 |
| 2025-12-12 | SHLEVIN, HAROLD H. | Director | Sale | 19,793 | — | — |
| 2025-12-12 | SHLEVIN, HAROLD H. | Director | Sale | 19,793 | $6.27 | $124181.28 |
| 2025-12-09 | SHLEVIN, HAROLD H. | Director | Sale | 16,790 | — | — |
| 2025-12-09 | SHLEVIN, HAROLD H. | Director | Sale | 16,790 | $6.27 | $105206.14 |
| 2025-12-08 | SHLEVIN, HAROLD H. | Director | Sale | 35,000 | — | — |
| 2025-12-08 | SHLEVIN, HAROLD H. | Director | Sale | 25,000 | — | — |
| 2025-12-08 | SHLEVIN, HAROLD H. | Director | Sale | 20,000 | — | — |
| 2025-12-08 | SHLEVIN, HAROLD H. | Director | Sale | 35,000 | — | — |
| 2025-12-08 | SHLEVIN, HAROLD H. | Director | Sale | 20,000 | — | — |
| 2025-12-08 | SHLEVIN, HAROLD H. | Director | Sale | 35,000 | $6.02 | $210665.00 |
| 2025-12-08 | SHLEVIN, HAROLD H. | Director | Sale | 25,000 | $5.95 | $148650.00 |
| 2025-12-08 | SHLEVIN, HAROLD H. | Director | Sale | 20,000 | $5.96 | $119240.00 |
| 2025-12-08 | SHLEVIN, HAROLD H. | Director | Sale | 4,000 | $6.01 | $24020.00 |
| 2025-12-08 | SHLEVIN, HAROLD H. | Director | Sale | 20,000 | $5.96 | $119240.00 |
| 2025-12-03 | 10X, FUND, L.P. | 10% Owner | Sale | 132,069 | $5.73 | $756755.37 |
| 2025-12-03 | 10X, FUND, L.P. | 10% Owner | Sale | 120,000 | $5.73 | $687600.00 |
| 2025-12-02 | 10X, FUND, L.P. | 10% Owner | Sale | 30,000 | $5.47 | $164100.00 |
| 2025-11-24 | 10X, FUND, L.P. | 10% Owner | Sale | 24,000 | — | — |
| 2025-11-18 | LEWIS, JOEL | Director, President and CEO | Sale | 6,783 | — | — |
| 2025-11-18 | LEWIS, JOEL | Director, President and CEO | Sale | 6,783 | $6.15 | $41722.91 |
| 2025-11-18 | CALLICUTT, JACK W | Chief Financial Officer | Sale | 28,120 | — | — |
| 2025-11-18 | CALLICUTT, JACK W | Chief Financial Officer | Sale | 18,190 | — | — |
| 2025-11-18 | CALLICUTT, JACK W | Chief Financial Officer | Buy | 28,100 | $1.98 | $55638.00 |
| 2025-11-18 | CALLICUTT, JACK W | Chief Financial Officer | Buy | 18,210 | $1.11 | $20213.10 |
| 2025-11-17 | LEWIS, JOEL | Director, President and CEO | Sale | 15,680 | — | — |
| 2025-11-17 | LEWIS, JOEL | Director, President and CEO | Buy | 15,680 | $2.39 | $37475.20 |
| 2025-11-17 | CALLICUTT, JACK W | Chief Financial Officer | Sale | 19,701 | — | — |
| 2025-11-17 | CALLICUTT, JACK W | Chief Financial Officer | Sale | 9,586 | — | — |
Frequently asked questions
Are GALT insiders buying or selling?
Over the transactions on record, GALT insiders have been net sellers, with about $4.24M in stock sold across 63 sales, against 17 open-market purchases.
Does insider selling at GALT mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which GALT insiders are selling the most?
Recent selling is concentrated in a few names. 10X, FUND, L.P. accounts for the largest share on record, with about $1.81M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.